Shanghai ZJ Bio-Tech Co. Ltd. A (688317) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.002x

Based on the latest financial reports, Shanghai ZJ Bio-Tech Co. Ltd. A (688317) has a cash flow conversion efficiency ratio of 0.002x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥6.85 Million ≈ $1.00 Million USD) by net assets (CN¥3.39 Billion ≈ $496.64 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Shanghai ZJ Bio-Tech Co. Ltd. A market cap and net worth for the company's overall valuation and market capitalisation.

Shanghai ZJ Bio-Tech Co. Ltd. A - Cash Flow Conversion Efficiency Trend (2013–2025)

This chart illustrates how Shanghai ZJ Bio-Tech Co. Ltd. A's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Shanghai ZJ Bio-Tech Co. Ltd. A Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Shanghai ZJ Bio-Tech Co. Ltd. A ranked by their cash flow conversion efficiency. Explore 688317 operating cash flow to net income to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Beijing Waluer Information Technology Co. Ltd. A
SHE:301380
-0.009x
Zhongjin Irradiation Incorporated Company
SHE:300962
0.043x
Kambi Group PLC
ST:KAMBI
0.086x
Akis Gayrimenkul Yatirim Ortakligi AS
IS:AKSGY
0.015x
Sichuan Etrol Technologies Co Ltd
SHE:300370
0.014x
Zhenhai PetroChem Engineering
SHG:603637
0.031x
Sijin Intelligent Forming Machinery
SHE:003025
0.057x
Binggrae
KO:005180
-0.014x

Annual Cash Flow Conversion Efficiency for Shanghai ZJ Bio-Tech Co. Ltd. A (2013–2025)

The table below shows the annual cash flow conversion efficiency of Shanghai ZJ Bio-Tech Co. Ltd. A from 2013 to 2025. View Shanghai ZJ Bio-Tech Co. Ltd. A share price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥3.35 Billion
≈ $490.04 Million
CN¥66.85 Million
≈ $9.78 Million
0.020x -6.43%
2024-12-31 CN¥3.64 Billion
≈ $532.19 Million
CN¥77.59 Million
≈ $11.35 Million
0.021x +199.65%
2023-12-31 CN¥3.82 Billion
≈ $559.71 Million
CN¥-81.88 Million
≈ $-11.98 Million
-0.021x -115.37%
2022-12-31 CN¥4.20 Billion
≈ $614.65 Million
CN¥584.97 Million
≈ $85.60 Million
0.139x -16.97%
2021-12-31 CN¥3.83 Billion
≈ $560.07 Million
CN¥641.94 Million
≈ $93.94 Million
0.168x -78.52%
2020-12-31 CN¥1.46 Billion
≈ $214.02 Million
CN¥1.14 Billion
≈ $167.08 Million
0.781x +482.33%
2019-12-31 CN¥571.84 Million
≈ $83.68 Million
CN¥76.66 Million
≈ $11.22 Million
0.134x -11.44%
2018-12-31 CN¥532.66 Million
≈ $77.95 Million
CN¥80.63 Million
≈ $11.80 Million
0.151x +49.06%
2017-12-31 CN¥472.70 Million
≈ $69.17 Million
CN¥48.00 Million
≈ $7.02 Million
0.102x +10.36%
2016-12-31 CN¥483.90 Million
≈ $70.81 Million
CN¥44.53 Million
≈ $6.52 Million
0.092x +147.38%
2015-12-31 CN¥343.47 Million
≈ $50.26 Million
CN¥12.78 Million
≈ $1.87 Million
0.037x -85.11%
2014-12-31 CN¥110.35 Million
≈ $16.15 Million
CN¥27.57 Million
≈ $4.03 Million
0.250x +4.71%
2013-12-31 CN¥118.03 Million
≈ $17.27 Million
CN¥28.16 Million
≈ $4.12 Million
0.239x --

About Shanghai ZJ Bio-Tech Co. Ltd. A

SHG:688317 China Medical Devices
Market Cap
$508.65 Million
CN¥3.48 Billion CNY
Market Cap Rank
#12351 Global
#3635 in China
Share Price
CN¥18.31
Change (1 day)
+6.89%
52-Week Range
CN¥15.05 - CN¥26.37
All Time High
CN¥80.15
About

Shanghai ZJ Bio-Tech Co., Ltd. engages in the research and development, production, and sale of molecular diagnostic reagents and instruments in China and internationally. The company offers nucleic acid and real-time PCR kits, as well as consumables. It serves public health safety and clinical diagnostics sectors. The company was founded in 2005 and is based in Shanghai, China.